Results 1 to 10 of about 81,008 (204)

Evaluating Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) and Osteoprotegerin (OPG) expression during canine retraction: A comparison between periodontal distraction versus conventional retraction [PDF]

open access: yesJournal of Orthodontic Science
OBJECTIVE: To evaluate and compare the expression levels of Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) and Osteoprotegerin (OPG) in canine periodontal tissues subjected to periodontal distraction versus conventional retraction at ...
Osama Eissa   +5 more
doaj   +2 more sources

ارتباط بین غلظت سرمی‎RANKL با اختلالات قلبی در بیماران بتا تالاسمی ‎ماژور [PDF]

open access: yesMajallah-i Dānishkadah-i Pizishkī-i Dānishgāh-i ̒ Ulūm-i Pizishkī-i Mashhad., 2020
چکیده مقدمه: بتا تالاسمی‎ ماژور  نوعی اختلال اتوزومال مغلوب است که با اریتروپوئز غیر موثر شناخته می‎شود. تزریق مداوم و ناتوانی بدن در  حذف آهن در بدن منجر به اضافه بار آهن شده که  باعث ایجاد صدمه به بافت قلب می‎شود.
الهام محمودی   +5 more
doaj   +1 more source

Bad to the bone: B cell acute lymphoblastic leukemia cells mediate bone destruction

open access: yesMolecular & Cellular Oncology, 2021
Skeletal morbidities continue to cause acute and long-term burdens for B-ALL patients underscoring the need to identify the mechanisms underlying these processes and to develop effective therapies.
Sujeetha A. Rajakumar, Jayne S. Danska
doaj   +1 more source

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts [PDF]

open access: yesRoyal Society Open Science, 2019
Osteoclasts are multinuclear giant cells that have unique ability to degrade bone. The search for new medicines that modulate the formation and function of osteoclasts is a potential approach for treating osteoclast-related bone diseases.
Liuliu Yan   +4 more
doaj   +1 more source

Evaluation of Isoflavones as Bone Resorption Inhibitors upon Interactions with Receptor Activator of Nuclear Factor-κB Ligand (RANKL)

open access: yesMolecules, 2020
Receptor activator of nuclear factor-κB ligand (RANKL) is a cytokine responsible for bone resorption. It binds its receptor RANK, which activates osteoporosis.
Małgorzata Zakłos-Szyda   +4 more
doaj   +1 more source

Research progress on the relationship between osteocytes and periodontitis

open access: yes口腔疾病防治, 2020
Osteocytes, which develop from osteoblasts, are recognized as the main cells embedded in mature bone tissue. The traditional notion is that osteocytes exclusively play a structural role, however, with the development of related research in recent years ...
ZHU Xuanzhi   +3 more
doaj   +1 more source

Medienkompetenzvermittlung im Fachgegenstand Musikerziehung

open access: yesMedienimpulse, 2014
Dieser Artikel befasst sich mit der Integration von Medienbildung in den Musikunterricht und behandelt Aspekte inwieweit musikerzieherische Inhalte auch zur Medienbildung beitragen können.
Martin Rankl
doaj   +1 more source

The Effects of Acute Exercise on RANKL/RANK/OPG Pathway and Bone Metabolic Markers in Healthy College Female [PDF]

open access: yes운동과학, 2018
PURPOSE The purpose of this study was to examine the effects of acute exercise with difference Intensitis on RANKL/RANK/OPG pathway and bone metabolic markers in healthy college female. METHODS Ten healthy college females (aged 21.5±1.84 years; VO2max 37.
Ji-Yeon Kim   +5 more
doaj   +1 more source

M CELLS ARE THE IMPORTANT POST IN THE INITIATION OF IMMUNE RESPONSE IN INTESTINE

open access: yesИнфекция и иммунитет, 2018
Microfold cells (M cells) are specialized intestinal epithelial cells that initiate mucosal immune responses. These unique phagocytic epithelial cells are specialized for the transfer of a broad range of particulate antigens and microorganisms across the
A. S. Bykov   +7 more
doaj   +1 more source

Inhibition of RANK signaling as a potential immunotherapy in breast cancer

open access: yesOncoImmunology, 2021
RANK signaling in mouse mammary tumor cells exerts an immunosuppressive environment by promoting the infiltration of pro-tumorigenic neutrophils and preventing CD8 T cell recruitment.
C Gómez-Aleza, E González-Suárez
doaj   +1 more source

Home - About - Disclaimer - Privacy